Day 3 Highlights - ESC Congress 2019

2 years 11 Views


Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease (AFIRE—0:35); effects of sacubitril-valsartan compared with enalapril on arterial hemodynamics and cardiac remodeling in patients with heart failure and reduced ejection fraction (EVALUATE-HF, PROVE-HF—4:39); using cardiolinguistics and artificial intelligence to reframe typical and atypical angina (HERMES—4:45), and the combined effect of lower LDL-C and lower systolic blood pressure on the lifetime risk of cardiovascular disease (LDL SBP—6:15). Visit for full meeting coverage.

Up next